Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nasopharyngeal Carcinoma”

509 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 509 results

Testing effectiveness (Phase 2)Study completedNCT00049140
What this trial is testing

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
David M. Brizel, MD 8
Not applicableNot Yet RecruitingNCT06572293
What this trial is testing

Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 250
Early research (Phase 1)Study completedNCT04945421
What this trial is testing

IBI310 in Combination With Siltilimab in Subjects With Anti-PD-1/PD-L1 Resistance R/M NPC

Who this might be right for
NPC
Innovent Biologics (Suzhou) Co. Ltd. 30
Not applicableStudy completedNCT00899821
What this trial is testing

Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
NYU Langone Health
Not applicableStudy completedNCT03788499
What this trial is testing

Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis

Who this might be right for
Nasopharyngeal Carcinoma
Xinqiao Hospital of Chongqing 160
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT02794077
What this trial is testing

Cyclophosphamide for Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Undifferentiated CarcinomaStage IV Nasopharyngeal Undifferentiated Carcinoma
The University of Hong Kong 56
Testing effectiveness (Phase 2)Study completedNCT00096512
What this trial is testing

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+34 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT04548271
What this trial is testing

Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 25
Early research (Phase 1)Ended earlyNCT05166577
What this trial is testing

Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC

Who this might be right for
Nasopharyngeal CarcinomaEBV-Related Gastric CarcinomaEBV-Related Leiomyosarcoma+2 more
Viracta Therapeutics, Inc. 26
Not applicableEnded earlyNCT00898430
What this trial is testing

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 49
Not applicableStudy completedNCT05834712
What this trial is testing

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 224
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047265
What this trial is testing

Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 164
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Large-scale testing (Phase 3)UnknownNCT02500940
What this trial is testing

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Taichung Veterans General Hospital 54
Very early researchEnded earlyNCT02582008
What this trial is testing

Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Current SmokerHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+4 more
Wake Forest University Health Sciences 9
Testing effectiveness (Phase 2)Study completedNCT00030576
What this trial is testing

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 51
Large-scale testing (Phase 3)Looking for participantsNCT05772208
What this trial is testing

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 459
Early research (Phase 1)Study completedNCT02759250
What this trial is testing

ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Cancer
argenx 11
Large-scale testing (Phase 3)Looking for participantsNCT06976190
What this trial is testing

MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Lepu Biopharma Co., Ltd. 446
Next Page